A multicenter, open-label study of vernakalant for the conversion of atrial fibrillation to sinus rhythm
Authors:
- 1 June 2010
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 159 (6) , 1095-1101
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Arrhythmic complications of electrical cardioversion: Relationship to shock energyInternational Journal of Cardiology, 2008
- Incidence of Early Adverse Events Surrounding Direct Current Cardioversion of Persistent Atrial Fibrillation. A Cohort Study of PracticesTherapies, 2007
- Pharmacologic approaches to rhythm versus rate control in atrial fibrillation—where are we now?International Journal of Cardiology, 2006
- The Mechanism of Atrial Antiarrhythmic Action of RSD1235Journal of Cardiovascular Electrophysiology, 2005
- Safety and efficacy of intravenously administered tedisamil for rapid conversion of recent-onset atrial fibrillation or atrial flutterJACC, 2004
- The incidence and severity of cutaneous burns following external DC cardioversionResuscitation, 2004
- Outpatient cardioversion of atrial arrhythmias: Efficacy, safety, and costsAmerican Heart Journal, 2003
- Meta-analysis of randomised controlled trials of the effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillationHeart, 2002
- Prevalence of Diagnosed Atrial Fibrillation in AdultsJAMA, 2001
- Dofetilide in Patients with Congestive Heart Failure and Left Ventricular DysfunctionNew England Journal of Medicine, 1999